+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Image-Based Cytometry in Cell Analysis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

  • PDF Icon

    Report

  • 116 Pages
  • September 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5882080
Description Jump to:

The image-based cytometry in cell analysis market is expected to grow at a CAGR of 10.50% during the forecast period of 2023 to 2031, image-based cytometry in cell analysis market is a dynamic sector that plays a pivotal role in advancing cell analysis and research through innovative imaging technologies. The Image-Based Cytometry in Cell Analysis Market is driven by technological advancements, personalized medicine trends, and the integration of AI and ML technologies. However, the complexity of data interpretation presents a challenge to harnessing the full potential of image-based cytometry. North America currently leads the market, while the Asia-Pacific region is projected to experience the highest growth. Industry leaders' strategies revolve around innovation, collaborations, and user-friendly solutions that empower researchers to unlock the complexities of cellular behavior through image-based cytometry.

Advancements in Imaging Technologies

The rapid evolution of imaging technologies has been a primary driver of Image Based Cytometry in the Cell Analysis Market. Innovations such as high-resolution microscopy, confocal microscopy, and super-resolution imaging have transformed cell analysis by enabling researchers to capture intricate cellular structures and dynamic processes at unprecedented levels of detail. These advancements have expanded the capabilities of image-based cytometry, making it an indispensable tool in various fields, including drug discovery, cancer research, and regenerative medicine.

Growing Demand for Personalized Medicine

The shift towards personalized medicine has fueled the demand for image-based cytometry in cell analysis. This approach requires a deep understanding of cellular behavior and heterogeneity, which image-based cytometry can provide through single-cell analysis. By examining individual cells within a heterogeneous population, researchers gain insights into cellular variations and responses, facilitating the development of targeted therapies and personalized treatment strategies.

Integration of Artificial Intelligence (AI) and Machine Learning (ML)

The integration of AI and ML technologies with image-based cytometry has revolutionized cell analysis. These technologies enable automated and high-throughput analysis of vast amounts of imaging data, allowing researchers to extract meaningful information efficiently. AI-driven image analysis enhances the speed and accuracy of cell analysis, aiding in the identification of subtle cellular changes, rare events, and complex patterns that might be missed using traditional manual approaches.

The Complexity of Data Interpretation

A significant restraint in the Image Based Cytometry in Cell Analysis Market is the complexity of data interpretation. The integration of advanced imaging technologies and AI-driven analysis generates vast amounts of data, which require expertise in both image analysis and biological interpretation. Researchers often face challenges in deciphering complex data sets, identifying relevant biological insights, and translating findings into actionable knowledge.

Biotechnology and Pharmaceutical Companies Dominate the End-User Segment

The market is segmented by end-user into Biotechnology and pharmaceutical Companies, Therapeutic Areas, Workplaces, Academia, Cosmetic Industry, Contract Research Organizations (CROs), and Contract Development and Manufacturing Organizations (CDMOs). Each segment encompasses distinct needs and applications for image-based cytometry. Biotechnology and pharmaceutical Companies are leveraging image-based cytometry for drug discovery and development, while academia utilizes it for fundamental research. CROs and CDMOs play a pivotal role in providing outsourced image-based cytometry services to support various industries. In 2022, biotechnology and pharmaceutical companies accounted for a significant portion of the market revenue. These industry players utilize image-based cytometry to enhance drug discovery, optimize treatment regimens, and monitor the effects of therapeutics at the cellular level. The adoption of image-based cytometry aids in identifying potential drug candidates, evaluating their mechanism of action, and assessing their impact on cellular pathways. As the demand for personalized medicine grows, biotechnology and pharmaceutical companies are projected to exhibit a robust Compound Annual Growth Rate (CAGR) from 2023 to 2031. This growth is attributed to the integration of high-content imaging technologies and advanced data analysis tools to accelerate drug development and improve treatment outcomes.

North America Remains as the Global Leader

North America dominated the Image Based Cytometry in Cell Analysis Market in 2022, driven by its robust research ecosystem, technological advancements, and significant investments in life sciences. Europe and the Asia-Pacific region also hold substantial market shares due to their growing research activities and expanding pharmaceutical and biotechnology sectors. The Asia-Pacific region is expected to exhibit the highest CAGR from 2023 to 2031. Rapidly growing economies, increasing research collaborations, and a rising focus on precision medicine contribute to the region's anticipated growth.

Market Competition to Intensify during the Forecast Period

Key players in the Image Based Cytometry in Cell Analysis Market include Thermo Fisher Scientific, BD Biosciences, PerkinElmer, Inc., GE Healthcare, Carl Zeiss AG, Merck KGaA, Sartorius AG, Charles River Laboratories, Yokogawa Electric Corporation, and Nanolive SA. These industry leaders focus on developing advanced imaging platforms, software solutions, and integrated systems that cater to diverse research needs. Strategic approaches involve partnerships with research institutions, technology collaborations, and the introduction of innovative imaging modalities. The market is characterized by a strong emphasis on user-friendly interfaces, automation, and software-driven analysis to enhance accessibility and ease of use.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofImage-Based Cytometry in Cell Analysis market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Image-Based Cytometry in Cell Analysis market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

End-User

  • Biotechnology & Pharmaceutical Companies
  • Therapeutic Area

Oncology & Immune-oncology

  •  Small Molecules
  •  Protein-based Therapeutics
  •  Cell Therapy
  •  Nucleic Acid-based Drugs

 Immunology

  • Small Molecules
  • Protein-based Therapeutics
  • Cell Therapy
  • Nucleic Acid-based Drugs

Rare Diseases

  • Small Molecules
  • Protein-based Therapeutics
  • Cell Therapy
  • Nucleic Acid-based Drugs

  Neurological Diseases

  • Small Molecules
  • Protein-based Therapeutics
  • Cell Therapy
  • Nucleic Acid-based Drugs

  Others

  • Small Molecules
  • Protein-based Therapeutics
  • Cell Therapy
  • Nucleic Acid-based Drugs

Workplace

  • Target Identification
  • Hit Generation & Lead Identification
  • Lead Optimization
  • In Vitro Preclinical Studies
  • In Vivo Preclinical Studies
  • Clinical Studies
  • Academia
  • Cosmetic Industry
  • Contract Research Organizations
  • Contract Development & Manufacturing Organizations

Region Segment (2021 - 2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Image-Based Cytometry in Cell Analysis market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Image-Based Cytometry in Cell Analysis market?
  • Which is the largest regional market for Image-Based Cytometry in Cell Analysis market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Image-Based Cytometry in Cell Analysis market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Image-Based Cytometry in Cell Analysis market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Image-Based Cytometry in Cell Analysis Market
2.2. Global Image-Based Cytometry in Cell Analysis Market, By End-User, 2022 (US$ Million)
2.3. Global Image-Based Cytometry in Cell Analysis Market, By Geography, 2022 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2022
3. Image-Based Cytometry in Cell Analysis Market: Competitive Analysis
3.1. Market Positioning of Key Image-Based Cytometry in Cell Analysis Market Vendors
3.2. Strategies Adopted by Image-Based Cytometry in Cell Analysis Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Image-Based Cytometry in Cell Analysis Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Image-Based Cytometry in Cell Analysis Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Biotechnology & Pharmaceutical Companies
5.3.2. Therapeutic Area
5.3.2.1. Oncology & Immune-oncology
5.3.2.1.1. Small Molecules
5.3.2.1.2. Protein-based Therapeutics
5.3.2.1.3. Cell Therapy
5.3.2.1.4. Nucleic Acid-based Drugs
5.3.2.2. Cardiovascular & Metabolic Diseases
5.3.2.2.1. Small Molecules
5.3.2.2.2. Protein-based Therapeutics
5.3.2.2.3. Cell Therapy
5.3.2.2.4. Nucleic Acid-based Drugs
5.3.2.3. Immunology
5.3.2.3.1. Small Molecules
5.3.2.3.2. Protein-based Therapeutics
5.3.2.3.3. Cell Therapy
5.3.2.3.4. Nucleic Acid-based Drugs
5.3.2.4. Rare Diseases
5.3.2.4.1. Small Molecules
5.3.2.4.2. Protein-based Therapeutics
5.3.2.4.3. Cell Therapy
5.3.2.4.4. Nucleic Acid-based Drugs
5.3.2.5. Neurological Diseases
5.3.2.5.1. Small Molecules
5.3.2.5.2. Protein-based Therapeutics
5.3.2.5.3. Cell Therapy
5.3.2.5.4. Nucleic Acid-based Drugs
5.3.2.6. Others
5.3.2.6.1. Small Molecules
5.3.2.6.2. Protein-based Therapeutics
5.3.2.6.3. Cell Therapy
5.3.2.6.4. Nucleic Acid-based Drugs
5.3.3. Workplace
5.3.3.1. Target Identification
5.3.3.2. Hit Generation & Lead Identification
5.3.3.3. Lead Optimization
5.3.3.4. In Vitro Preclinical Studies
5.3.3.5. In Vivo Preclinical Studies
5.3.3.6. Clinical Studies
5.3.4. Academia
5.3.5. Cosmetic Industry
5.3.6. Contract Research Organizations
5.3.7. Contract Development & Manufacturing Organizations
6. North America Image-Based Cytometry in Cell Analysis Market, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
6.3.Image-Based Cytometry in Cell Analysis Market: By Region, 2021-2031, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
7. UK and European Union Image-Based Cytometry in Cell Analysis Market, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
7.3.Image-Based Cytometry in Cell Analysis Market: By Region, 2021-2031, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
7.3.1.5. France
7.3.1.5.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
8. Asia Pacific Image-Based Cytometry in Cell Analysis Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
8.3.Image-Based Cytometry in Cell Analysis Market: By Region, 2021-2031, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
8.3.1.3. India
8.3.1.3.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
9. Latin America Image-Based Cytometry in Cell Analysis Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
9.3.Image-Based Cytometry in Cell Analysis Market: By Region, 2021-2031, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
10. Middle East and Africa Image-Based Cytometry in Cell Analysis Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
10.3.Image-Based Cytometry in Cell Analysis Market: By Region, 2021-2031, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Image-Based Cytometry in Cell Analysis Market: By End-User, 2021-2031, USD (Million)
11. Company Profile
11.1. Thermo Fisher Scientific
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. BD Biosciences
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. PerkinElmer, Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. GE Healthcare
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Carl Zeiss AG
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Merck KGaA
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Sartorius AG
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Charles River Laboratories
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Yokogawa Electric Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Nanolive SA
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Other Notable Players
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
List of Figures
Figure 1 Global Image-Based Cytometry in Cell Analysis Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Image-Based Cytometry in Cell Analysis Market: Quality Assurance
Figure 5 Global Image-Based Cytometry in Cell Analysis Market, By End-User, 2022
Figure 6 Global Image-Based Cytometry in Cell Analysis Market, By Geography, 2022
Figure 7 Market Geographical Opportunity Matrix - Global Image-Based Cytometry in Cell Analysis Market, 2022
Figure 8 Market Positioning of Key Image-Based Cytometry in Cell Analysis Market Players, 2022
Figure 9 Global Image-Based Cytometry in Cell Analysis Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 10 Global Image-Based Cytometry in Cell Analysis Market, By End-User, 2022 Vs 2031, %
Figure 11 U.S. Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 12 Canada Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 13 Rest of North America Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 14 UK Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 15 Germany Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 16 Spain Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 17 Italy Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 18 France Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 19 Rest of Europe Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 20 China Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 21 Japan Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 22 India Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 23 Australia Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 24 South Korea Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 25 Rest of Asia Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 26 Brazil Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 27 Mexico Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 28 Rest of Latin America Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 29 GCC Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 30 Africa Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
Figure 31 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 2 Global Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 3 Global Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 4 Global Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 5 Global Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 6 Global Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 7 Global Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 8 Global Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 9 Global Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 10 North America Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 11 North America Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 12 North America Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 13 North America Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 14 North America Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 15 North America Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 16 North America Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 17 North America Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 18 North America Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 19 U.S. Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 20 U.S. Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 21 U.S. Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 22 U.S. Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 23 U.S. Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 24 U.S. Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 25 U.S. Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 26 U.S. Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 27 U.S. Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 28 Canada Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 29 Canada Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 30 Canada Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 31 Canada Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 32 Canada Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 33 Canada Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 34 Canada Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 35 Canada Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 36 Canada Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 37 Rest of North America Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 38 Rest of North America Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 39 Rest of North America Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 40 Rest of North America Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 41 Rest of North America Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 42 Rest of North America Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 43 Rest of North America Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 44 Rest of North America Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 45 Rest of North America Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 46 UK and European Union Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 47 UK and European Union Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 48 UK and European Union Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 49 UK and European Union Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 50 UK and European Union Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 51 UK and European Union Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 52 UK and European Union Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 53 UK and European Union Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 54 UK and European Union Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 55 UK Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 56 UK Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 57 UK Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 58 UK Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 59 UK Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 60 UK Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 61 UK Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 62 UK Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 63 UK Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 64 Germany Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 65 Germany Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 66 Germany Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 67 Germany Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 68 Germany Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 69 Germany Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 70 Germany Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 71 Germany Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 72 Germany Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 73 Spain Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 74 Spain Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 75 Spain Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 76 Spain Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 77 Spain Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 78 Spain Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 79 Spain Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 80 Spain Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 81 Spain Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 82 Italy Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 83 Italy Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 84 Italy Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 85 Italy Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 86 Italy Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 87 Italy Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 88 Italy Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 89 Italy Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 90 Italy Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 91 France Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 92 France Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 93 France Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 94 France Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 95 France Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 96 France Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 97 France Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 98 France Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 99 France Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 100 Rest of Europe Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 101 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 102 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 103 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 104 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 105 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 106 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 107 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 108 Rest of Europe Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 109 Asia Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 110 Asia Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 111 Asia Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 112 Asia Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 113 Asia Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 114 Asia Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 115 Asia Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 116 Asia Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 117 Asia Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 118 China Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 119 China Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 120 China Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 121 China Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 122 China Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 123 China Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 124 China Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 125 China Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 126 China Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 127 Japan Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 128 Japan Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 129 Japan Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 130 Japan Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 131 Japan Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 132 Japan Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 133 Japan Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 134 Japan Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 135 Japan Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 136 India Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 137 India Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 138 India Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 139 India Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 140 India Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 141 India Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 142 India Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 143 India Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 144 India Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 145 Australia Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 146 Australia Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 147 Australia Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 148 Australia Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 149 Australia Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 150 Australia Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 151 Australia Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 152 Australia Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 153 Australia Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 154 South Korea Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 155 South Korea Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 156 South Korea Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 157 South Korea Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 158 South Korea Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 159 South Korea Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 160 South Korea Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 161 South Korea Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 162 South Korea Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 163 Latin America Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 164 Latin America Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 165 Latin America Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 166 Latin America Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 167 Latin America Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 168 Latin America Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 169 Latin America Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 170 Latin America Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 171 Latin America Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 172 Brazil Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 173 Brazil Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 174 Brazil Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 175 Brazil Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 176 Brazil Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 177 Brazil Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 178 Brazil Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 179 Brazil Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 180 Brazil Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 181 Mexico Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 182 Mexico Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 183 Mexico Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 184 Mexico Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 185 Mexico Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 186 Mexico Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 187 Mexico Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 188 Mexico Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 189 Mexico Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 190 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 191 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 192 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 193 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 194 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 195 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 196 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 197 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 198 Rest of Latin America Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 199 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 200 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 201 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 202 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 203 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 204 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 205 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 206 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 207 Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 208 GCC Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 209 GCC Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 210 GCC Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 211 GCC Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 212 GCC Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 213 GCC Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 214 GCC Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 215 GCC Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 216 GCC Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 217 Africa Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 218 Africa Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 219 Africa Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 220 Africa Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 221 Africa Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 222 Africa Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 223 Africa Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 224 Africa Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 225 Africa Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)
Table 226 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By End-User, 2021-2031, USD (Million)
Table 227 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Therapeutic Area, 2021-2031, USD (Million)
Table 228 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Oncology & Immune-oncology, 2021-2031, USD (Million)
Table 229 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Cardiovascular & Metabolic Diseases, 2021-2031, USD (Million)
Table 230 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Immunology, 2021-2031, USD (Million)
Table 231 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Rare Diseases, 2021-2031, USD (Million)
Table 232 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Neurological Diseases, 2021-2031, USD (Million)
Table 233 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Others, 2021-2031, USD (Million)
Table 234 Rest of Middle East and Africa Image-Based Cytometry in Cell Analysis Market By Workplace, 2021-2031, USD (Million)

Companies Mentioned

  • Thermo Fisher Scientific
  • BD Biosciences
  • PerkinElmer, Inc.
  • GE Healthcare
  • Carl Zeiss AG
  • Merck KGaA
  • Sartorius AG
  • Charles River Laboratories
  • Yokogawa Electric Corporation
  • Nanolive SA

Related Topics

Related Reports

Global Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Forecast to 2028 - Product Image

Global Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Forecast to 2028

  • Report
  • 242 Pages
  • Global
From
Global Single Cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Forecast to 2028 - Product Image

Global Single Cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Forecast to 2028

  • Report
  • 332 Pages
  • Global
From
Single Cell Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Single Cell Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 181 Pages
  • Global
From
Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 148 Pages
  • Global
From
Global Cell Analysis Market by Product (Cell Counters, Cell Microarrays, Flow Cytometry Products), Process (Cell Counting & Quality Control, Cell Identification, Cell Interaction), End-User - Forecast 2024-2030 - Product Image

Global Cell Analysis Market by Product (Cell Counters, Cell Microarrays, Flow Cytometry Products), Process (Cell Counting & Quality Control, Cell Identification, Cell Interaction), End-User - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From

About the Image Based Cytometry Market

Image-based cytometry is a technique employed within the field of genomics to analyze physical and functional characteristics of cells. Used in conjunction with genomic data, image-based cytometry allows researchers to visualize and quantify phenotypic attributes in cells, which can be correlated with genetic information. This integration is crucial for advancing personalized medicine, high-throughput screening, and our understanding of complex biological systems and diseases. The technology is increasingly adopted in genomics for its ability to provide high-resolution images and perform multiplex analysis, enabling simultaneous examination of multiple cellular parameters, gene expressions, and genotypic characteristics within individual cells or cell populations. In the nexus of genomics and cellular analysis, the image-based cytometry market comprises companies that specialize in the development and manufacturing of cytometry instruments, software, and reagents. Companies play a pivotal role in advancing research and clinical applications by investing in technology that facilitates the detailed exploration of the genome and its manifestation in cellular behavior. Important players in this market segment include Becton, Dickinson and Company (BD), Thermo Fisher Scientific, Danaher Corporation (parent company of Beckman Coulter), Bio-Rad Laboratories, and Agilent Technologies. Each of these companies provides a range of cytometry solutions customizable for various genomic applications, and their products are commonly found in research laboratories, academic institutions, and clinical settings. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.